In a phase 2 experiment, the Crohn’s disease medication developed by Ventyx Bios...
The European agency said that Leqembi’s efficacy was “not large enough” to outwe...
EMA’s COMP has adopted positive opinions for two orphan medicinal product design...
The European Commission (EC) has granted approval to a €2bn Dutch measure to pro...
The US FDA has granted approval for Luye Pharma’s ERZOFRI extended-release injec...
Bristol Myers Squibb (BMS) has posted net income attributable to the company of ...
The EMA CHMP has recommended approving MSD’s KEYTRUDA regimen as a first-line tr...
Osteoporosis is the most common metabolic bone disorder worldwide and is the lea...
SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutica...
Clinical trial trends point to studying combination therapies and lifestyle chan...
The CHMP recommendation is based on positive results from the Phase IIb EFFISAYI...
California should take urgent and bold measures to adapt its $59 billion agricul...
In 1953, 15-year-old Joe Ligon and four other Pennsylvania teens went on an alco...
Los Angeles, California – July 29, 2024 – Terasaki Institute scientists have cre...
Inspired by the paper-folding art of origami, North Carolina State University en...
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, anno...
